|Bid||25.06 x 1100|
|Ask||25.09 x 27000|
|Day's range||24.90 - 25.40|
|52-week range||22.00 - 54.75|
|Beta (5Y monthly)||1.08|
|PE ratio (TTM)||27.08|
|Earnings date||14 Oct 2020|
|Forward dividend & yield||0.40 (1.59%)|
|Ex-dividend date||06 Aug 2020|
|1y target est||29.83|
Industry-first partnership between Pallium Canada and Boehringer Ingelheim Canada aims to expand access to palliative care, even as pandemic creates new challenges BURLINGTON, ON, Sept. 18, 2020 /CNW/ - With the need for palliative care at a crisis point in Canada and COVID-19 adding unprecedented new challenges, an innovative initiative has launched to build capacity and promote earlier, more effective and more compassionate care.
CEO Brian Moynihan said he believes the issue of deferrals is largely behind the bank at this point.
After falling sharply between February and May with the rapid onset of the coronavirus pandemic, investor optimism showed little improvement in August despite the market rally.